"The Rakai Health Sciences Program (RHSP) is both a research and service organisation with operations in over 12 districts in the greater Masaka Region including but limited to Mpigi, Kyotera, Masaka, Bukomansimbi, Lyantonde, Sembabule and Rakai. The Services and Research studies include provision of ARV, Male Circumcision, Health Education, Pharmacy, Clinical Services and Rakai Community Study Cohort. ETT and Stylish Campaign. The Rakai Health Sciences Program (RHSP) was established in 1987 as a collaboration between researchers at Makerere, Columbia and John Hopkins Universities, the Division of Intramural Research at the National Institutes of Allergy & Infectious diseases and the International Centre for Excellence Research (ICER)."

During the past decade, Rakai Health Sciences Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rakai Health Sciences Program" #1 sponsor was "Johns Hopkins Bloomberg School of Public Health" with 4 trials, followed by "Johns Hopkins University" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Rakai Health Sciences Program" with 2 trials sponsored and "Wawer, Maria J., M.D." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rakai Health Sciences Program" #1 collaborator was "Rakai Health Sciences Program" with 6 trials as a collaborator, "Bill and Melinda Gates Foundation" with 3 trials as a collaborator, "Johns Hopkins Bloomberg School of Public Health" with 2 trials as a collaborator, "George Washington University" with 1 trials as a collaborator and "Jhpiego" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Rakai Health Sciences Program" are "HIV" (7 trials), "Acceptability of Different Contraceptive Injection Types" (1 trials), "Adherence" (1 trials), "Bacterial Vaginosis" (1 trials) and "CD4 Deficiency" (1 trials). Many other conditions were trialed in "Rakai Health Sciences Program" in a lesser frequency.

Most popular intervention types in "Rakai Health Sciences Program" are "Behavioral" (5 trials), "Other" (3 trials), "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DepoSubQ Provera 104 in Uniject" (1 trials), "HealthScouts" (1 trials), "Intramuscular DMPA" (1 trials), "Male circumcision" (1 trials) and "Mass Media" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rakai Health Sciences Program" are 9 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rakai Health Sciences Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Rakai Health Sciences Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rakai Health Sciences Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".